Section 1 Introduction to Applying Research |
|
1 | (102) |
|
1 What Is Evidence-Based Practice? |
|
|
2 | (18) |
|
Evidence-Based Practice In Exercise Science And Health Care |
|
|
4 | (2) |
|
Role of Evidence in the Practitioner's Decision-Making Process |
|
|
5 | (1) |
|
|
6 | (14) |
|
Centre for Evidence-Based Medicine Hierarchy |
|
|
7 | (6) |
|
Level 5: "First Principles," Physiological Evidence and Bench Research, Expert Opinion |
|
|
8 | (1) |
|
Level 4: Case-Series and Poor-Quality Cohort or Case-Control Studies |
|
|
9 | (1) |
|
Level 3b: Individual Case-Control Study |
|
|
9 | (1) |
|
Level 3a: Systematic Review of Case-Control Studies |
|
|
10 | (1) |
|
Level 2c: Outcomes Research and Ecological Studies |
|
|
10 | (1) |
|
Level 2b: Individual Cohort Study or Low-Quality Randomized Controlled Trial |
|
|
11 | (1) |
|
Level 2a: Systematic Review of Cohort Studies |
|
|
11 | (1) |
|
|
12 | (1) |
|
Level 1b: Individual Randomized Controlled Trial |
|
|
12 | (1) |
|
Level 1a: Systematic Reviews of Randomized Controlled Trials |
|
|
12 | (1) |
|
Centre for Evidence-Based Medicine Pyramid for Other Studies |
|
|
13 | (1) |
|
Alternative Levels of Evidence |
|
|
13 | (1) |
|
Base and Shape of the Evidence Pyramid |
|
|
14 | (1) |
|
Strength of Recommendation Taxonomy |
|
|
15 | (5) |
|
2 Answering a Clinically Relevant Question |
|
|
20 | (28) |
|
|
22 | (26) |
|
1 Asking Focused Questions: Translating Uncertainty to an Answerable Question (Ask) |
|
|
22 | (3) |
|
|
22 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
24 | (1) |
|
2 Finding the Evidence: Systematic Retrieval of Best Evidence Available (Acquire) |
|
|
25 | (11) |
|
|
26 | (8) |
|
|
34 | (2) |
|
3 Critical Appraisal: Testing Evidence for Validity, Clinical Relevance, and Applicability (Appraise) |
|
|
36 | (2) |
|
|
36 | (1) |
|
Assessing Clinical Relevance |
|
|
37 | (1) |
|
|
38 | (1) |
|
4 Making a Decision: Application of Results in Practice (Act) |
|
|
38 | (4) |
|
Client Values and Priorities |
|
|
38 | (2) |
|
Were Clinically Meaningful Outcomes Studied? |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
Dealing With Inadequate Science |
|
|
42 | (1) |
|
5 Evaluating Performance: Auditing Evidence-Based Decisions (Analyze and Adjust) |
|
|
42 | (8) |
|
|
42 | (1) |
|
|
43 | (5) |
|
3 Outcome Measures in Health and Exercise Science |
|
|
48 | (20) |
|
|
50 | (2) |
|
World Health Organization Model |
|
|
50 | (2) |
|
Types Of Measures Or Outcomes |
|
|
52 | (16) |
|
Disease-Oriented Evidence |
|
|
52 | (1) |
|
Patient-Oriented Evidence That Matters |
|
|
53 | (1) |
|
Clinician-Based Outcomes Measures |
|
|
53 | (2) |
|
Patient-Based Outcomes Measures |
|
|
55 | (9) |
|
Disease-Specific Outcomes |
|
|
55 | (1) |
|
|
56 | (2) |
|
Dimension-Specific Outcomes |
|
|
58 | (2) |
|
|
60 | (1) |
|
|
61 | (2) |
|
|
63 | (1) |
|
Properties of Patient-Based Outcomes |
|
|
63 | (1) |
|
Performance-Based Assessments |
|
|
64 | (4) |
|
|
68 | (35) |
|
|
70 | (1) |
|
Measures Of Central Tendency |
|
|
71 | (4) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
73 | (2) |
|
|
75 | (5) |
|
|
75 | (1) |
|
Standard Error and Confidence Intervals |
|
|
76 | (4) |
|
|
80 | (6) |
|
|
81 | (5) |
|
|
84 | (1) |
|
|
85 | (1) |
|
Caveats of Test-Retest Reliability |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
86 | (4) |
|
|
87 | (2) |
|
|
87 | (2) |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
90 | (1) |
|
Clinimetric Properties Of Measurement |
|
|
90 | (14) |
|
Minimal Detectable Change |
|
|
91 | (2) |
|
Minimal Important Difference |
|
|
93 | (4) |
|
|
93 | (2) |
|
Issues and Cautions Using Minimal Important Difference |
|
|
95 | (1) |
|
Sensitivity- and Specificity-Based Approach |
|
|
96 | (1) |
|
Distribution-Based Approach |
|
|
96 | (1) |
|
Social Comparison Approach |
|
|
97 | (1) |
|
Minimal Clinical Important Difference |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
98 | (1) |
|
Floor and Ceiling Effects |
|
|
98 | (5) |
Section 2 Establishing Cause and Effect |
|
103 | (58) |
|
|
104 | (26) |
|
The Basic Experimental Design |
|
|
106 | (1) |
|
Internal Validity Of Research |
|
|
107 | (6) |
|
|
107 | (6) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (7) |
|
Pre-experimental Research Designs |
|
|
114 | (2) |
|
True Experimental Designs |
|
|
116 | (2) |
|
|
118 | (1) |
|
Quasi-experimental Designs |
|
|
118 | (4) |
|
Nonequivalent Control Group Design |
|
|
119 | (1) |
|
Interrupted Time-Series Design |
|
|
119 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
External Validity Of Research |
|
|
122 | (3) |
|
Targets of Generalization |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
Similar or Different Kind |
|
|
125 | (1) |
|
Random Sample to Population |
|
|
125 | (1) |
|
Threats to External Validity |
|
|
125 | (1) |
|
Tradeoffs Between Internal And External Validity |
|
|
125 | (1) |
|
Links Among Internal, Construct, And External Validity |
|
|
126 | (4) |
|
6 Clinical (Therapeutic) Trials |
|
|
130 | (31) |
|
Efficacy Versus Effectiveness |
|
|
133 | (1) |
|
|
133 | (3) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
136 | (15) |
|
Randomized Controlled Trial |
|
|
136 | (8) |
|
|
137 | (3) |
|
|
140 | (2) |
|
|
142 | (2) |
|
Nonrandomized Concurrent Control |
|
|
144 | (1) |
|
Historical Control Designs |
|
|
144 | (2) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
147 | (1) |
|
|
148 | (2) |
|
|
150 | (1) |
|
|
151 | (2) |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
154 | (2) |
|
|
156 | (1) |
|
Assessment Of Treatment Harm |
|
|
157 | (4) |
Section 3 Other Methods in Clinical Research |
|
161 | (52) |
|
|
162 | (28) |
|
|
Diagnostic Statistics For Accuracy |
|
|
164 | (12) |
|
Sensitivity and Specificity |
|
|
164 | (3) |
|
True-Positive, True-Negative, False-Positive, and False-Negative Results |
|
|
167 | (1) |
|
Clinical Diagnostic Usefulness for Sensitivity and Specificity |
|
|
167 | (2) |
|
Positive Predictive Value and Negative Predictive Value |
|
|
169 | (1) |
|
Relationship Between Prevalence and Predictive Values |
|
|
170 | (3) |
|
Positive Likelihood Ratio and Negative Likelihood Ratio |
|
|
173 | (3) |
|
Example Of Diagnostic Accuracy Statistics |
|
|
176 | (3) |
|
Receiver Operating Characteristic Curves |
|
|
179 | (13) |
|
Optimal Cutoff Score on a Receiver Operating Characteristic Curve |
|
|
180 | (3) |
|
|
183 | (2) |
|
Decision-Making With Diagnostic Statistics |
|
|
185 | (5) |
|
8 Epidemiological Methods in Sport and Exercise Science |
|
|
190 | (23) |
|
|
|
192 | (2) |
|
|
194 | (5) |
|
Disease or Injury Occurrence |
|
|
194 | (1) |
|
Variation in Occurrence of Disease or Injury |
|
|
195 | (1) |
|
Epidemiological Measures of Prevention |
|
|
196 | (3) |
|
Study Designs In Epidemiological Research |
|
|
199 | (5) |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
201 | (2) |
|
Randomized Clinical Trial or Randomized Controlled Trial |
|
|
203 | (1) |
|
|
204 | (4) |
|
|
205 | (1) |
|
Consistency of Association |
|
|
205 | (1) |
|
Specificity of Association |
|
|
205 | (1) |
|
|
206 | (1) |
|
Biological Gradient or Dose Response |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
|
207 | (1) |
|
Epidemiological Decision-Making |
|
|
208 | (8) |
|
|
208 | (1) |
|
|
208 | (5) |
Section 4 Synthesizing and Evaluating Research |
|
213 | (57) |
|
|
214 | (34) |
|
Primary Study Versus Secondary Study |
|
|
216 | (1) |
|
|
216 | (6) |
|
|
217 | (1) |
|
|
218 | (1) |
|
Bias in Narrative Reviews |
|
|
218 | (4) |
|
|
222 | (13) |
|
Methods of Searching for and Assessing Data |
|
|
222 | (9) |
|
|
222 | (1) |
|
Included Study Populations and Reporting of Subject Characteristics |
|
|
223 | (1) |
|
Identified Outcomes and Study Designs |
|
|
224 | (1) |
|
|
224 | (2) |
|
Inclusion and Exclusion Criteria |
|
|
226 | (2) |
|
Assessment of Primary Study Quality |
|
|
228 | (1) |
|
|
228 | (3) |
|
Process of Synthesizing Data |
|
|
231 | (4) |
|
|
231 | (2) |
|
|
233 | (2) |
|
|
235 | (13) |
|
|
235 | (2) |
|
Fixed Versus Random Effects |
|
|
237 | (1) |
|
|
238 | (4) |
|
|
238 | (4) |
|
|
242 | (1) |
|
Methodological Quality Assessment in Meta-Analysis |
|
|
242 | (2) |
|
|
244 | (4) |
|
10 Evaluating Research Quality |
|
|
248 | (22) |
|
|
Research And The Scientific Method |
|
|
250 | (4) |
|
Science: Method Not Madness |
|
|
250 | (1) |
|
Not All Questions Are Good |
|
|
251 | (1) |
|
Hypotheses Are Tested, Not Proven |
|
|
252 | (1) |
|
Methodology: How You Did It Matters |
|
|
253 | (1) |
|
|
254 | (1) |
|
Discussions: Do Not Let Results Get Lost In The Interpretation |
|
|
255 | (1) |
|
|
255 | (25) |
|
|
258 | (1) |
|
Centre for Evidence-Based Medicine |
|
|
259 | (1) |
|
|
260 | (1) |
|
Consolidated Standards of Reporting Trials |
|
|
260 | (1) |
|
Meta-Analysis of Observational Studies in Epidemiology |
|
|
261 | (1) |
|
Physiotherapy Evidence Database |
|
|
263 | (1) |
|
Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
|
|
264 | (1) |
|
Strength of Recommendation Taxonomy |
|
|
265 | (5) |
Appendices |
|
|
|
270 | (6) |
|
|
270 | (1) |
|
Biomechanics And Kinesiology |
|
|
270 | (1) |
|
|
270 | (1) |
|
Medical And General Science |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
|
273 | (1) |
|
|
273 | (1) |
|
|
273 | (1) |
|
|
273 | (3) |
|
B Professional Organization Research-Based Stands and Statements |
|
|
276 | (4) |
|
American College Of Sports Medicine Position Stands |
|
|
276 | (1) |
|
National Athletic Trainers' Association Position Statements |
|
|
277 | (1) |
|
National Athletic Trainers' Association Consensus Statements |
|
|
278 | (2) |
|
C The Disablement Continuum |
|
|
280 | (11) |
|
The Disablement Continuum |
|
|
280 | (7) |
|
The National Center for Medical Rehabilitation Research Model |
|
|
281 | (3) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
282 | (1) |
|
|
283 | (1) |
|
|
284 | (1) |
|
The Updated National Center for Medical Rehabilitation Research Model |
|
|
284 | (1) |
|
The World Health Organization Model |
|
|
285 | (1) |
|
Institute of Medicine Model |
|
|
285 | (2) |
|
Selecting A Disablement Model |
|
|
287 | (4) |
|
Extending the Model to Human Performance |
|
|
287 | (4) |
Glossary |
|
291 | (16) |
Index |
|
307 | |